ArticleHealth science reports2026
Occupational Exposure to UPVC Powder Containing Calcium Carbonate (CaCO
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Nanomaterials are widely produced and used due to their unique physicochemical properties. Adding nano calcium carbonate to Unplasticized PolyVinyl Chloride (UPVC) improves durability and sustainability. Studies have shown that occupational exposure to UPVC powder can affect the health of employees. There are also such studies about occupational exposure to nanomaterials. Therefore, this study seeks to investigate occupational exposure to a combination of these substances. Methods: This is a cross-sectional Descriptive-analytical study conducted in 2022 at a company utilizing UPVC powder containing calcium carbonate nanoparticles in Tehran province. In this study, biomarkers of oxidative stress (Malondialdehyde (MDA), Superoxide Dismutase (SOD), and Total Antioxidant Capacity (TAC)) were measured in the blood of 100 employees. Also, the activities involved with nanomaterials were assessed for risk using the Nanotool method. Results: Seventeen participants were female, and 83 were male. The mean ± standard deviation for age and work experience was 35 ± 9 and 6 ± 5 years, respectively. MDA, SOD, and TAC levels were elevated in the exposed group compared to controls. These differences were significant only in the case of TAC. Among the 12 activities investigated, 6 activities (50%) showed the maximum risk level. The high levels of biomarkers observed in the exposure group compared to the control groups (TAC Conclusion: Findings suggest that exposure to powders containing nanomaterials may endanger the health of employees and shows the importance of adhering to safety principles when working with powders containing nanomaterials in the investigated company and across the broader nanomaterials industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.